Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Exercise therapy after corticosteroid injection for moderate to severe shoulder pain: large pragmatic randomised trial [with consumer summary]
Crawshaw DP, Helliwell PS, Hensor EMA, Hay EM, Aldous SJ, Conaghan PG
BMJ 2010 Jun 28;340:c3037
clinical trial
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

OBJECTIVE: To compare the effectiveness of subacromial corticosteroid injection combined with timely exercise and manual therapy (injection plus exercise) or exercise and manual therapy alone (exercise only) in patients with subacromial impingement syndrome. DESIGN: Pragmatic randomised clinical trial. SETTING: Primary care based musculoskeletal service. Patients Adults aged 40 or over with subacromial impingement syndrome with moderate or severe shoulder pain. INTERVENTIONS: Injection plus exercise or exercise only. MAIN OUTCOME MEASURES: Primary outcome was the difference in improvement in the total shoulder pain and disability index at 12 weeks. RESULTS: 232 participants were randomised (115 to injection plus exercise, 117 to exercise only). The mean age was 56 (range 40 to 78), 127 were women, and all had had a median of 16 weeks of shoulder pain (interquartile range 12 to 28). At week 12 there was no significant difference between the groups in change in total pain and disability index (mean difference between change in groups 3.26 (95% confidence interval -0.81 to 7.34), p = 0.116). Improvement was significantly greater in the injection plus exercise group at week 1 (6.56, 4.30 to 8.82) and week 6 (7.37, 4.34 to 10.39) for the total pain and disability index (p < 0.001), with no differences at week 24 (-2.26, -6.77 to 2.25, p = 0.324). CONCLUSIONS: In the treatment of patients with subacromial impingement syndrome, injection plus exercise and exercise only are similarly effective at 12 weeks. TRIAL REGISTRATION: ISRCT25817033; EudraCT No 2005-003628-20.
Reproduced with permission from the BMJ Publishing Group.

Full text (sometimes free) may be available at these link(s):      help